Global Nucleic Acid Testing Market to Grow due to High Incidence of Infectious Diseases

A blood sample being held with a row of human samples for analytical testing including blood, urine, chemistry, proteins, anticoagulants and HIV in lab

With its new research report, Transparency Market Research presents a well-researched case of the global nucleic acid testing market. The research report, titled “Nucleic Acid Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” evaluates the overall market using SWOT analysis to point out the strengths, weaknesses, opportunities, and threats governing the market segments of the global nucleic acid testing market. Additionally, it also includes Porter’s five forces analysis to highlight the intensity of competitive rivalry, the bargaining power of suppliers, the threat of new entrants, the bargaining power of customers, and the threat of substitute products or services. The researchers have studied historical data pertaining to the global nucleic acid testing market and compared it to the current market scenario to provide a clear picture of the trajectory of this market for the near future.

A complete Brochure for This Research Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1834

The primary growth drivers for the global nucleic acid testing market are the high incidence of infectious diseases and other chronic diseases such as cancer and genetic diseases. Furthermore, the increasing demand for technological advancements in ways of testing, rising acceptance from end users, and supportive regulatory framework are also expected to drive the global nucleic acid testing market. Research indicates that about one billion people fell prey to infectious diseases in 2012, which has lent a huge impetus to this market and will become the deciding factor in its growth trajectory in the coming years.

The global nucleic acid testing market is segmented on the basis of application into infectious diseases, cancer, genetic diseases, paternity testing, and forensic testing. On the basis of process, this market is segmented into sample pooling and nucleic acid (NA) extraction, target amplicon NA detection, and target NA amplification. Depending on the technology, this market is segmented into transcription-mediated amplification (TMA), polymerase chain reaction (PCR), ligase chain reaction (LCR), strand displacement amplification (SDA), and nucleic acid sequence based amplification (NASBA). Geographically, this market is segmented into North America, Asia Pacific, Europe, and Rest of the World.

Request For Customize Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1834

Some of the important players in the global nucleic acid testing market are Gen-Probe, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Siemens Healthcare, Bio-Rad Laboratories, Inc., Illumina, Inc., bioMérieux SA, Novartis AG, F. Hoffmann-La Roche Ltd., Sequenom, Inc. Tecan Group Ltd., and Beckman Coulter, Inc. The research report profiles these players and offers a detailed explanation of how the market’s competitive landscape is going to pan out in the coming few years. Additionally, the report also provides an analysis of the financial overview, research and development strategies, investment outlook, business and marketing strategies, and strategic mergers and acquisitions of these top players for the near future.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s